Novel 30-amp MOSES versus MOSES 2.0 pulse-modulation technologies for holmium laser enucleation of the prostate (HoLEP)

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Elmansy H.; Mousa A.; Hodhod A.; Abdul Hadi R.; Nour H.; Alharbi M.; Berjaoui M.B.; Tayebi S.-L.; Morgan M.; Gonzalez R.R.; Zakaria A.S.

Journal: World Journal of Urology

Publisher: Springer Science and Business Media Deutschland GmbH

Publication Date: 22 June 2026

Volume / Issue: Volume 44 / Issue 1

Article No.: 449

ISSN: 7244983

DOI: 10.1007/s00345-026-06530-x

Scopus: View on Scopus

PubMed: 42329295

Document Type: Article


Authors and Affiliations

Elmansy H., Houston Methodist Hospital, Houston, TX, United States; Mousa A., Thunder Bay Regional Health Sciences Centre, Northern Ontario School of Medicine, Thunder Bay, ON, Canada, Theodor Bilharz Research Institute, Giza, Egypt; Hodhod A., King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia; Abdul Hadi R., Thunder Bay Regional Health Sciences Centre, Northern Ontario School of Medicine, Thunder Bay, ON, Canada; Nour H., Theodor Bilharz Research Institute, Giza, Egypt; Alharbi M., Qassim University, Qassim, Buraydah, Saudi Arabia; Berjaoui M.B., University of Toronto, Toronto, ON, Canada; Tayebi S.-L., Western University, London, ON, Canada; Morgan M., Houston Methodist Hospital, Houston, TX, United States; Gonzalez R.R., Houston Methodist Hospital, Houston, TX, United States; Zakaria A.S., Thunder Bay Regional Health Sciences Centre, Northern Ontario School of Medicine, Thunder Bay, ON, Canada


Abstract

Purpose: We aimed to compare early perioperative and functional outcomes of holmium laser enucleation of the prostate (HoLEP) performed with the 30-amp MOSES system and MOSES 2.0 technology. Methods: We retrospectively compared 65 patients who underwent HoLEP with the 30-amp MOSES system and 210 with MOSES 2.0 between June 2023 and April 2025.Intraoperative and perioperative outcomes were collected and analyzed at 1, 3, and 6 months postoperatively. Results: The two groups had comparable preoperative characteristics, with median prostate volumes of 105 and 111 cc in the MOSES 2.0 and 30-amp MOSES groups, respectively (p = 0.22). Intraoperatively, the MOSES 2.0 group demonstrated an 8-minute shorter median enucleation time (p = 0.007), a 3-minute shorter median hemostasis time (p < 0.001), and lower energy use (75.7 vs. 92.1 kJ, p < 0.001). Additionally, MOSES 2.0 demonstrated superior enucleation efficiency compared to 30-amp MOSES (2.2 vs. 2 g/min, p = 0.047). Other operative parameters were comparable between the two groups. Both technologies achieved comparable successful same-day trial of void rates of 94% in the MOSES 2.0 group and 93.4% in the 30-amp MOSES group (p = 0.88). Postoperative functional outcomes, including IPSS, QoL, Qmax, PVR, and PSA, were comparable between groups up to 6 months of follow-up. Conclusion: HoLEP with 30-amp MOSES technology is a safe and effective option for treating benign prostatic obstruction. Both MOSES systems support same-day discharge with comparable safety and functional outcomes. The 30-amp MOSES system may offer a practical alternative for institutions without a dedicated 50-amp power supply. Large randomized controlled trials with longer follow-up are warranted. © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2026.


Keywords

Benign prostatic hyperplasia; Laser prostate surgery; MOSES technology; Prostate; Aged; Humans; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Prostatectomy; Prostatic Hyperplasia; Retrospective Studies; Treatment Outcome; comparative study; devices; drug therapy; human; procedures; prostate hypertrophy; retrospective study; solid state laser; surgery


Citation Information

Scopus Citations: 0


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region